Mathys Matters June 2024
In this edition:
- Spotlight of the month: Unified Patent Court captures 15% of European patent litigation but still far from being primary European patent court
- Changes to the proposed new medicinal products Directive have been approved by the EU Parliament – do they shift the balance between generics and innovators and are they TRIPS compliant?
- Mathys & Squire files Petition for Review for Ipsen Bioinnovation
- Mathys & Squire recognised as one of Europe’s leading patent firms in the Financial Times 2024 rankings
- Fifteen Mathys & Squire attorneys recognised in IAM Patent 1000 2024
Mathys Matters May 2024
In this edition:
- Spotlight of the month: Number of drone patents filed worldwide jumps 16% in past year
- Does an inventive process entitle you to a claim to an obvious product?
- Mathys & Squire promotes three experts to partners
- Patenting materials in medical devices at the EPO
- Update on Mathys & Squire test case in support of open justice
Mathys Matters April 2024
In this edition:
- Spotlight of the month: UPC releases pleadings to the public, but questions remain
- Mathys & Squire celebrates World IP Day 2024: IP and the SDGs
- Will G1/23 introduce an “on-sale bar” at the EPO?
- Mathys & Squire announces the appointment of a new Partner in Munich
- Building the future with nature: Boosting biotechnology and biomanufacturing in the EU
